Granted Patent
B2
US 12,221,472 · App. 18/168,824 · Granted Feb 11, 2025
Compositions and methods for the removal of biofilms
C07K16/1242A01N37/46A61K39/0208A61K39/39541A61K39/40A61K45/06C07K16/12C07K16/1232C07K16/40G01N33/56911G01N33/6854G01N33/6893A61K2039/505C07K2317/34C07K2317/76G01N2500/04G01N2800/24
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This disclosure provides isolated or recombinant polypeptides that are useful to vaccinate individuals suffering from chronic/recurrent biofilm disease or as a therapeutic for those with an existing infection. The individual's immune system will then naturally generate antibodies which prevent or clear these bacteria from the host by interfering with the construction and or maintenance of a functional protective biofilm. Alternatively, antibodies to the polypeptides can be administered to treat or prevent infection. Bacteria that cannot form functional biofilms are more readily cleared by the remainder of the host's immune system and/or traditional antibiotics.
Claims (26)
1. An isolated polypeptide consisting of (a) an amino acid sequence selected from MATITKLDIIEYLSDKYHLS (SEQ ID NO: 348), KYHLSKQDTKNVVENFLEEI (SEQ ID NO: 349), FLEEIRLSLESGQDVKLSGF (SEQ ID NO: 350), KLSGFGNFELRDKSSRPGRN (SEQ ID NO: 351), RPGRNPKTGDVVPVSARRVV (SEQ ID NO: 352), or ARRVVTFKPGQKLRARVEKTK (SEQ ID NO: 353), and (b) a heterologous amino acid sequence selected from:
(i) up to 20 random amino acids on the amine terminus of the amino acid sequence in (a); or
(ii) up to 15 random amino acids on the carboxy terminus of the amino acid sequence in (a).
2. An isolated polypeptide consisting of
(a) an amino acid sequence selected from MATITKLDIIEYLSDKYHLS (SEQ ID NO: 348), KYHLSKQDTKNVVENFLEEI (SEQ ID NO: 349), FLEEIRLSLESGQDVKLSGF (SEQ ID NO: 350), KLSGFGNFELRDKSSRPGRN (SEQ ID NO: 351), RPGRNPKTGDVVPVSARRVV (SEQ ID NO: 352), or ARRVVTFKPGQKLRARVEKTK (SEQ ID NO: 353), and
(b) a heterologous amino acid sequence selected from:
(i) up to 20 random amino acids on the amine terminus of the amino acid sequence in (a); or
(ii) up to 15 random amino acids on the carboxy terminus of the amino acid sequence in (a); and
(c) a heterologous non-peptide domain.
3. An isolated polypeptide consisting of
(a) an amino acid sequence selected from MATITKLDIIEYLSDKYHLS (SEQ ID NO: 348), KYHLSKQDTKNVVENFLEEI (SEQ ID NO: 349), FLEEIRLSLESGQDVKLSGF (SEQ ID NO: 350), KLSGFGNFELRDKSSRPGRN (SEQ ID NO: 351), RPGRNPKTGDVVPVSARRVV (SEQ ID NO: 352), or ARRVVTFKPGQKLRARVEKTK (SEQ ID NO: 353),
(b) a heterologous amino acid sequence selected from:
(i) up to 20 random amino acids on the amine terminus of the amino acid sequence in (a); or
(ii) up to 15 random amino acids on the carboxy terminus of the amino acid sequence in (a); and
(c) a detectable label.
4. A composition consisting of an isolated polypeptide consisting of an amino acid sequence selected from: MATITKLDIIEYLSDKYHLS (SEQ ID NO: 348), KYHLSKQDTKNVVENFLEEI (SEQ ID NO: 349), FLEEIRLSLESGQDVKLSGF (SEQ ID NO: 350), KLSGFGNFELRDKSSRPGRN (SEQ ID NO: 351), RPGRNPKTGDVVPVSARRVV (SEQ ID NO: 352), or ARRVVTFKPGQKLRARVEKTK (SEQ ID NO: 353), and a pharmaceutically acceptable carrier.
5. A composition consisting of an isolated polypeptide consisting of an amino acid sequence and a detectable label, wherein the amino acid sequence is selected from: MATITKLDIIEYLSDKYHLS (SEQ ID NO: 348), KYHLSKQDTKNVVENFLEEI (SEQ ID NO: 349), FLEEIRLSLESGQDVKLSGF (SEQ ID NO: 350), KLSGFGNFELRDKSSRPGRN (SEQ ID NO: 351), RPGRNPKTGDVVPVSARRVV (SEQ ID NO: 352), or ARRVVTFKPGQKLRARVEKTK (SEQ ID NO: 353).
6. A composition consisting of an isolated polypeptide consisting of an amino acid sequence selected from: MATITKLDIIEYLSDKYHLS (SEQ ID NO: 348), KYHLSKQDTKNVVENFLEEI (SEQ ID NO: 349), FLEEIRLSLESGODVKLSGF (SEQ ID NO: 350), KLSGFGNFELRDKSSRPGRN (SEQ ID NO: 351), RPGRNPKTGDVVPVSARRVV (SEQ ID NO: 352), or ARRVVTFKPGQKLRARVEKTK (SEQ ID NO: 353) and an adjuvant.
7. The composition of claim 4 , wherein the pharmaceutically acceptable carrier is selected from one or more of: an ion exchanger, a buffer, a saturated vegetable fatty acid, a salt, an electrolyte, a cellulose-based substance, an elixir, a buffering agent, a DNAse I, an antimicrobial, a preservative, a lubricant, a stabilizer, a glidant, or a flavoring agent.
8. A composition consisting of an isolated polypeptide consisting of an amino acid sequence selected from: MATITKLDIIEYLSDKYHLS (SEQ ID NO: 348), KYHLSKQDTKNVVENFLEEI (SEQ ID NO: 349), FLEEIRLSLESGODVKLSGF (SEQ ID NO: 350), KLSGFGNFELRDKSSRPGRN (SEQ ID NO: 351), RPGRNPKTGDVVPVSARRVV (SEQ ID NO: 352), or ARRVVTFKPGQKLRARVEKTK (SEQ ID NO: 353) and a pharmaceutically acceptable carrier and an adjuvant.
9. The composition of claim 8 ,
wherein the pharmaceutically acceptable carrier is selected from an ion exchanger, a buffer, a saturated vegetable fatty acid, a salt, an electrolyte, a cellulose-based substance, an elixir, a buffering agent, a DNAse I, an antimicrobial, a preservative, a lubricant, a stabilizer, a glidant, or a flavoring agent.
10. A composition consisting of an isolated polypeptide consisting of (a) an amino acid sequence selected from MATITKLDIIEYLSDKYHLS (SEQ ID NO: 348), KYHLSKQDTKNVVENFLEEI (SEQ ID NO: 349), FLEEIRLSLESGQDVKLSGF (SEQ ID NO: 350), KLSGFGNFELRDKSSRPGRN (SEQ ID NO: 351), RPGRNPKTGDVVPVSARRVV (SEQ ID NO: 352), or ARRVVTFKPGQKLRARVEKTK (SEQ ID NO: 353), and (b) a heterologous amino acid sequence selected from:
(i) up to 20 random amino acids on the amine terminus of the amino acid sequence in (a); or
(ii) up to 15 random amino acids on the carboxy terminus of the amino acid sequence in (a) and a pharmaceutically acceptable carrier or an adjuvant.
11. The composition of claim 10 , wherein the pharmaceutically acceptable carrier is selected from an ion exchanger, a buffer, a saturated vegetable fatty acid, a salt, an electrolyte, a cellulose-based substance, an elixir, a buffering agent, a DNAse I, an antimicrobial, a preservative, a lubricant, a stabilizer, a glidant, or a flavoring agent.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 21, 2024
From: GOODMAN, STEVEN D.; BAKALETZ, LAUREN O.
To: RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
Reel/Frame 067484/0531 →
Continuity (8)
Continuation
PCTUS2014042201
· Jun 12, 2014
Provisional Application
62199952
· Jul 31, 2015
Provisional Application
61834846
· Jun 13, 2013
References Cited (381)
US 5549908A
· Smith et al.
· 1996
[cited by applicant]
US 6486314B1
· Van Geel-Schutten et al.
· 2002
[cited by applicant]
US 6551795B1
· Rubenfield et al.
· 2003
[cited by applicant]
US 6663863B2
· Horvath et al.
· 2003
[cited by applicant]
US 6696550B2
· Larosa et al.
· 2004
[cited by applicant]
US 6846651B2
· Fleischmann et al.
· 2005
[cited by applicant]
US 7241867B2
· Bakaletz et al.
· 2007
[cited by applicant]
US 7413868B2
· Kauvar et al.
· 2008
[cited by applicant]
US 7435595B2
· Boehm et al.
· 2008
[cited by applicant]
US 7638282B2
· Bakaletz et al.
· 2009
[cited by applicant]
US 7811591B2
· Bakaletz et al.
· 2010
[cited by applicant]
US 7816086B2
· Bakaletz et al.
· 2010
[cited by applicant]
US 7939344B2
· Kauvar et al.
· 2011
[cited by applicant]
US 7981676B2
· Boehm et al.
· 2011
[cited by applicant]
US 7998490B2
· Bakaletz et al.
· 2011
[cited by applicant]
US 8236494B2
· Bakaletz et al.
· 2012
[cited by applicant]
US 8283114B2
· Bakaletz et al.
· 2012
[cited by applicant]
US 8329187B2
· Lazzari et al.
· 2012
[cited by applicant]
US 8628917B2
· Bakaletz et al.
· 2014
[cited by applicant]
US 8652773B2
· Bakaletz et al.
· 2014
[cited by applicant]
US 8758764B2
· Masignani et al.
· 2014
[cited by applicant]
US 8933029B2
· Mcnicol et al.
· 2015
[cited by applicant]
US 8999291B2
· Goodman et al.
· 2015
[cited by applicant]
US 9017656B2
· Hancock et al.
· 2015
[cited by applicant]
US 9034642B2
· Bakaletz et al.
· 2015
[cited by applicant]
US 9155792B2
· Cottarel et al.
· 2015
[cited by applicant]
US 9278069B2
· Berkland et al.
· 2016
[cited by applicant]
US 9504739B2
· Berkes et al.
· 2016
[cited by applicant]
US 9554590B2
· Quintens et al.
· 2017
[cited by applicant]
US 9603878B2
· Berry et al.
· 2017
[cited by applicant]
US 9610307B2
· Berry et al.
· 2017
[cited by applicant]
US 9687449B2
· Harel
· 2017
[cited by applicant]
US 9713631B2
· Berkes et al.
· 2017
[cited by applicant]
US 9717765B2
· Berkes et al.
· 2017
[cited by applicant]
US 9745366B2
· Goodman et al.
· 2017
[cited by applicant]
US 20020132753A1
· Rosen et al.
· 2002
[cited by applicant]
US 20030060410A1
· Tracey et al.
· 2003
[cited by applicant]
US 20030099602A1
· Levin et al.
· 2003
[cited by applicant]
US 20030229065A1
· Levy et al.
· 2003
[cited by applicant]
US 20050059633A1
· Van Geel-Schuten
· 2005
[cited by applicant]
US 20050112235A1
· Shefer et al.
· 2005
[cited by applicant]
US 20050131222A1
· Fleischmann et al.
· 2005
[cited by applicant]
US 20050266069A1
· Simmons et al.
· 2005
[cited by applicant]
US 20060030539A1
· Nick et al.
· 2006
[cited by applicant]
US 20060121047A1
· Tracey
· 2006
[cited by applicant]
US 20060240045A1
· Berthet et al.
· 2006
[cited by applicant]
US 20070154529A1
· Bullerdiek
· 2007
[cited by applicant]
US 20070286822A1
· Sanders et al.
· 2007
[cited by applicant]
US 20090029929A1
· Nakajima et al.
· 2009
[cited by applicant]
US 20090297555A1
· Kemble et al.
· 2009
[cited by applicant]
US 20100291177A1
· Hermans et al.
· 2010
[cited by applicant]
US 20100303723A1
· Farokhzad et al.
· 2010
[cited by applicant]
US 20110008493A1
· Zorea
· 2011
[cited by applicant]
US 20110027328A1
· Baig et al.
· 2011
[cited by applicant]
US 20120128701A1
· Goodman et al.
· 2012
[cited by applicant]
US 20120148615A1
· Masignani et al.
· 2012
[cited by applicant]
US 20120189558A1
· Prendergast
· 2012
[cited by applicant]
US 20120247993A1
· Palazzi et al.
· 2012
[cited by applicant]
US 20130183323A1
· Wang
· 2013
[cited by applicant]
US 20140120107A1
· Bakaletz et al.
· 2014
[cited by applicant]
US 20150086561A1
· Kauvar et al.
· 2015
[cited by applicant]
US 20150166641A1
· Goodman et al.
· 2015
[cited by applicant]
US 20150197558A1
· Kauvar et al.
· 2015
[cited by applicant]
US 20150218231A1
· Bakaletz et al.
· 2015
[cited by applicant]
US 20150290140A1
· Singh et al.
· 2015
[cited by applicant]
US 20150299298A1
· Kauvar et al.
· 2015
[cited by applicant]
US 20160089363A1
· Borody
· 2016
[cited by applicant]
US 20160175440A1
· Goodman et al.
· 2016
[cited by applicant]
US 20160193258A1
· Berry et al.
· 2016
[cited by applicant]
US 20160194384A1
· Goodman et al.
· 2016
[cited by applicant]
US 20160235792A1
· Berry et al.
· 2016
[cited by applicant]
US 20160271188A1
· Berry et al.
· 2016
[cited by applicant]
US 20160289278A1
· Bakaletz et al.
· 2016
[cited by applicant]
US 20160340650A1
· Wagner et al.
· 2016
[cited by applicant]
US 20170182205A1
· Zupancic et al.
· 2017
[cited by applicant]
US 20170196915A1
· Czarnecki-Maulden et al.
· 2017
[cited by applicant]
US 20170215417A1
· Bhushan et al.
· 2017
[cited by applicant]
US 20170296600A1
· Rangavajla
· 2017
[cited by applicant]
US 20180207067A1
· Goodman et al.
· 2018
[cited by applicant]
JP 2005519998A
· 2005
[cited by applicant]
JP 2006506441A
· 2006
[cited by applicant]
JP 2006506467A
· 2006
[cited by applicant]
JP 2008520552A
· 2008
[cited by applicant]
JP 2013529893A
· 2013
[cited by applicant]
WO WO9850018A1
· 1998
[cited by applicant]
WO WO0047104A2
· 2000
[cited by applicant]
WO WO02077183A2
· 2002
[cited by applicant]
WO WO02085295
· 2002
[cited by applicant]
WO WO03026691A1
· 2003
[cited by applicant]
WO WO03026691A2
· 2003
[cited by applicant]
WO WO03083045A2
· 2003
[cited by applicant]
WO WO2004014418A2
· 2004
[cited by applicant]
WO WO2004044001A2
· 2004
[cited by applicant]
WO WO2004072094A2
· 2004
[cited by applicant]
WO WO2004078949A2
· 2004
[cited by examiner]
WO WO2005025604A2
· 2005
[cited by applicant]
WO WO2005111066A2
· 2005
[cited by applicant]
WO WO2006017816A2
· 2006
[cited by applicant]
WO WO2006083301A2
· 2006
[cited by applicant]
WO WO2006114805A2
· 2006
[cited by applicant]
WO WO2006138527
· 2006
[cited by applicant]
WO WO2007001422A2
· 2007
[cited by applicant]
WO WO2009006699A1
· 2009
[cited by applicant]
WO WO2010138522A2
· 2010
[cited by applicant]
WO WO2011123396A1
· 2011
[cited by applicant]
WO WO2012034090A1
· 2012
[cited by applicant]
WO WO2013088045A1
· 2013
[cited by applicant]
WO WO2013177596A2
· 2013
[cited by applicant]
WO WO2014067976A1
· 2014
[cited by applicant]
WO WO2014121304A1
· 2014
[cited by applicant]
WO WO2014201305A1
· 2014
[cited by applicant]
WO WO2015038339A1
· 2015
[cited by applicant]
WO WO2015048484A2
· 2015
[cited by applicant]
WO WO2016154491A1
· 2016
[cited by applicant]
WO WO2017192594A1
· 2017
[cited by applicant]
WO WO2018042385A2
· 2018
[cited by applicant]
WO WO2018187615A1
· 2018
[cited by applicant]
WO WO2019112978A2
· 2019
[cited by applicant]
WO WO2020038963A1
· 2020
[cited by applicant]
WO WO2020092554A1
· 2020
[cited by applicant]
WO WO2021007260A2
· 2021
[cited by applicant]
U.S. Appl. No. 15/649,352, filed Jul. 13, 2017.
[cited by applicant]
U.S. Appl. No. 16/746,708, filed Jan. 17, 2020.
[cited by applicant]
U.S. Appl. No. 17/150,731, filed Jan. 15, 2021.
[cited by applicant]
Adams et al., “D-158. Epitope-mapping the immune response of children with otitis media and adults with chronic obstructive pulmonary disease to the PilA protein of nontypeable Haemophilus influenzae type IV pilus,” 107…
[cited by applicant]
Adams et al., “Epitope-mapping the immune response of children with otitis media and adults with chronic obstructive pulmonary disease to the PilA protein of nontypeable Haemophilus influenzae type IV pilus,” Immunology…
[cited by applicant]
Allaker et al., “Non-conventional therapeutics for oral infections,” Virulence, vol. 6, No. 3, Apr. 2015, pp. 196-207.
[cited by applicant]
Andersson et al. (2011) “HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection,” Annu. Rev. Immunol. 29:139-162.
[cited by applicant]
Bakaletz et al., “New strategies to target bacterial biofilms”, 28th Annual North American Cystic Fibrosis Conference (NACFC), Atlanta, GA, Oct. 9-11, 2014 (presentation), 2 pages.
[cited by applicant]
Bakaletz et al., “Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chincilla,” Vaccine, v…
[cited by applicant]
Bakaletz et al., “Protection against Development of Otitis Media Induced by Nontypeable Haemophilus influenzae by Both Active and Passive Immunization in a Chinchilla Model of Virus-Bacterium Superinfection,” Infection …
[cited by applicant]
Bakaletz, “Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid associated proteins”, 6th ASM Conference on Biofilms, Miami, FL, Sep. 29-Oct. 4, 2012 (presentation), 5 pages.
[cited by applicant]
Bakaletz, L.O., Targeting the biofilm for development of novel preventative and therapeutic vaccine candidates to prevent otitis media, 6th ASM Conference on Biofilms, Miami, FL, Sep. 29-Oct. 4, 2012 (presentation), 5 p…
[cited by applicant]
Barve et al., “Cloning and characterization of the mating type (MAT) locus from Ascochyta rabiei (teleomorph: Didymella rabiei) and a MAT phylogeny of legume-associated
[cited by applicant]
Bass, et al. “Extracellular DNA: A Major Proinflammatory Component of Pseudomonas aeruginosa Biofilms,” The Journal of Immunology, (2010) 184:6386-6395.
[cited by applicant]
Beech, et al. “Microbe-surface interactions in biofouling and biocorrosion processes,” International Microbiology (2005) 8:157-168.
[cited by applicant]
Ben et al., “Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli,” World Journal of Gastroenterology, vol. 14, No. 42, Nov. 14, 2008, pp. 6564-6568.
[cited by applicant]
Bjarnsholt, “The role of bacterial biofilms in chronic infections,” APMIS (2013) 121(Suppl. 136):1-51.
[cited by applicant]
Boles et al., “Staphylococcal biofilm disassembly,” Trends in Microbiology (2011) 19(9):449-455.
[cited by applicant]
Brady et al., “Identification of Staphylococcus aureus Proteins Recognized by the Antibody-Mediated Immune Response to a Biofilm Infection,” Infection and Immunity (2006) 74(6):3415-3426.
[cited by applicant]
Brandstetter et al., “Antibodies Directed Against Integration Host Factor Mediate Biofilm Clearance From Nasopore,” The Laryngoscope, vol. 12, No. 11, Nov. 2013, pp. 2626-2632.
[cited by applicant]
Brinkmann et al., “Neutrophil extracellular traps kill bacteria”, Science. 2004; 303(5663):1532-5. doi: 10.1126/science. 1092385.
[cited by applicant]
Brockson et al., “Evaluation of the kinetics and mechanism of action anti-integration host factor-mediated disruption of bacterial biofilms: Anti-IHF-mediated biofilm collapse”, Molecular Microbiology, Epub Aug. 19, 201…
[cited by applicant]
Brockson et al., “Evaluation of the kinetics and mechanism of action of anti-integration host factor-mediated disruption of bacterial biofilms,” Molecular Microbiology, vol. 93, No. 6, Aug. 19, 2014, pp. 1246-1258, Supp…
[cited by applicant]
Brockson et al., “Evaluation of the kinetics and mechanism of action of anti-integration host factor-mediated disruption of bacterial biofilms,” Molecular Microbiology, vol. 93, No. 6, Aug. 19, 2014, pp. 1246-1258.
[cited by applicant]
Brockson, et al., “Evaluation of the kinetics and mechanism of action of anti-integration host factor-mediated disruption of bacterial biofilms”, Molecular microbiology. 2014; 93(6): 1246-58. Epub Jul. 30, 2014.
[cited by applicant]
Catlin, “Extracellular Deoxyribonucleic Acid of Bacteria and a Deoxyribonuclease Inhibitor,” Science, vol. 124, Sep. 7, 1956, pp. 441-442.
[cited by applicant]
Ceri, et al., “The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms,” Journal of Clinical Microbiology (1999) 37(6):1771-1776.
[cited by applicant]
Chen et al., “Novel Strategies for the Prevention and Treatment of Biofilm Related Infections,” Int. J. Mol. Sci., vol. 14, Sep. 6, 2013, pp. 18488-18501.
[cited by applicant]
Chen et al., “Substrate specificity of Helicobacter pylori histone-like HU protein is determined by insufficient stabilization of DNA flexure points,” Biochem J. (2004) 383:343-351.
[cited by applicant]
Cho et al., “The modulation of the biological activities of mitochondrial histone Abf2p by yeast PKA and its possible role in the regulation of mitochondrial DNA content during glucose repression,” Biochimica et Biophys…
[cited by applicant]
Coenye et al., “In vitro and in vivo model systems to study microbial biofilm formation,” Journal of Microbiological (2010) Methods 83:89-105.
[cited by applicant]
Cohavy et al. “Identification of a Novel Mycobacterial Histone H1 Homologue (HupB) as an Antigenic Target of pANCA Monoclonal Antibody and Serum Immunoglobulin A from Patients with Cohn's Disease,” Infection and Immunit…
[cited by applicant]
Collarini, et al., “Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients,” J Immunol (2009) 183:6338-6345.
[cited by applicant]
Dalai, et al. “Histone-like protein H-NS regulates biofilm formation and virulence of Actinobacillus pheuropneumonia,” (2009) Microbial Pathogenesis 46:128-134.
[cited by applicant]
Darouiche et al., “Treatment of Infections Associated with Surgical Implants,” N Engl J Med (2004) 350:1422-1429.
[cited by applicant]
Darvaj et al., “DNABII proteins play a central role in UPEC biofilm structure”, Molecular microbiology. Jun. 2015. 96(6):1119-35, doi: 10.1111/mmi. 12994. Epub Apr. 16, 2015.
[cited by applicant]
Darveau, “Periodontitis: a polymicrobial disruption of host homeostasis”, Nature reviews Microbiology, vol. 8, No. 7, Jul. 2010, pp. 481-490.
[cited by applicant]
Darveau, “The oral microbial consortium's interaction with the periodontal innate defense system”, DNA and cell biology. 2009; 28(8):389-95. Epub May 14, 2009. doi:10.1089/dna.2009.0864.
[cited by applicant]
De La Fuente-Nunez et al., “Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response,” PLoS Pathog., vol. 10, No. 5, May 2014, pp. 1-12.
[cited by applicant]
Devaraj et al., “DNABII proteins play a central role in UPEC biofilm structure”, Molecular Microbiology, 2015, vol. 96, vol. 6, Jun. 2015, pp. 1119-1135.
[cited by applicant]
Dominguez-Herrera, et al., “Efficacy of Daptomycin versus Vancomycin in an Experimental Model of Foreign-Body and Systemic Infection Caused by Biofilm Producers and Methicillin-Resistant
[cited by applicant]
Donlan, et al. “Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms,” Clinical Microbiology Reviews (2002) 15(2):167-193.
[cited by applicant]
Durocher et al., “High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells,” Nucleic Acids Research, vol. 30, No. 2, e9, Nov. 11, 2001, 9 pages.
[cited by applicant]
Dzink et al., “The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases”, Journal of clinical periodontology, vol. 15, No. 5, Sep. 8, 1987, pp. 316-323.
[cited by applicant]
Eboigbodin, et al., “Characterization of the Extracellular Plymeric Substances Produced by
[cited by applicant]
Eke et al., “Prevalence of periodontitis in adults in the United States: 2009 and 2010,” Journal of dental research. 2012; 91(10):914-20. Epub Sep. 1, 2019. doi: 10.1177/0022034512457373.
[cited by applicant]
Estelles et al., “A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model,” Antimicrobial Agents and Chemotherapy…
[cited by applicant]
Estrela et al., “Combining Biofilm-Controlling Compounds and Antibiotics as a Promising New Way to Control Biofilm Infections,” Pharmaceuticals, vol. 3, May 11, 2010, pp. 1374-1393.
[cited by applicant]
Falciola et al., “Mutational analysis of the DNA binding domain A of chromosomal protein HMG1,” Nucleic Acids Research, vol. 22, No. 3, Jan. 10, 1994, pp. 285-292.
[cited by applicant]
Fan, et al., “HMG2 Interacts with the Nucleosome Assembly Protein SET and Is a Target of the Cytotoxic T-Lymphocyte Protease Granzyme A,” Molecular and Cellular Biology (2002) 22(8):2810-2820.
[cited by applicant]
Fedorov, et al., “Kinase Inhibitor Selectivity Profiling Using Differential Scanning Fluorimetry,” Kinase Inhibitors: Methods and Protocols, Methods in Molecular Biology (2012) 795:109-118.
[cited by applicant]
Final Office Action in U.S. Appl. No. 15/078,987 dated Dec. 28, 2016, 12 pages.
[cited by applicant]
Final Office Action on U.S. Appl. No. 14/967,228 dated Nov. 22, 2017, 26 pages.
[cited by applicant]
First Examination Report on AU Application No. 2014324761 dated May 31, 2019, 4 pages.
[cited by applicant]
Foreign Search Report on EP 19219328.2 DTD Jul. 15, 2020.
[cited by applicant]
Garcia-Contreras et al., “Protein Translation and Cell Death: The Role of Rare tRNAs in Biofilm Formation and in Activating Dormant Phage Killer Genes,” PLoS ONE, vol. 3, No. 6, Jun. 11, 2008, e2394, 17 pages.
[cited by applicant]
Gerstel et al., “Complex Regulation of csgD Promoter Activity by Global Regulatory Proteins,” Molecular Microbiology, vol. 49, No. 3, Aug. 2003, pp. 639-654.
[cited by applicant]
Goldenberg et al., “Genetic and biochemical analysis of IHF/HU hybrid proteins”, BioChimie, vol. 76, No. 10-11, Jan. 1, 1994, pp. 941-950.
[cited by applicant]
Goodman et al., “Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins”, Advances in Mucosal Immunology, Jun. 29, 2011, pp. 1-13.
[cited by applicant]
Goodman et al., “Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins”, Mucosal Immuno, Nature Publishing Group, vol. 4, No. 6, Nov. 1, 2011, pp. 625-637.
[cited by applicant]
Goodman et al., “In Vitro Selection of Integration Host Factor Binding Sites,” Journal of Bacteriology, vol. 181, No. 10, May 1999, pp. 3246-3255.
[cited by applicant]
Goodman et al., “Replacement of Integration Host Factor Protein-induced DNA Bending by Flexible Regions of DNA,” The Journal of Biological Chemistry, vol. 274, No. 52, Aug. 6, 1999, pp. 37004-37011.
[cited by applicant]
Goodman, “A new immunotherapeutic approach that disperses biofilms, Banff Conference on Infectious Diseases”, Banff, Alberta, Canada, May 18, 2012 (presentation), 9 pages.
[cited by applicant]
Goodman, “Making and breaking biofilms”, Ohio Branch American Society for Microbiology Annual Meeting, Columbus, OH, Apr. 11-12, 2014 (presentation), 12 pages.
[cited by applicant]
Goodman, “Nucleoprotein complexes in the extracellular matrix are critical for the structural integrity of bacterial biofilms”, 112th General Meeting, American Society for Microbiology, San Francisco, CA, Jun. 18, 2012 …
[cited by applicant]
Goodman, “The DNABII family of proteins: Diagnostic markers and therapeutic targets of bacterial biofilms”, International Congress on Bacteriology and Infectious Disease, Baltimore, MD, Nov. 21, 2013, 7 pages.
[cited by applicant]
Goshima et al., “Chimeric HU-IHF proteins that alter DNA-binding ability,” GENE, vol. 118, No. 1, Sep. 1, 1992, pp. 97-102.
[cited by applicant]
Govan et al., “Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia,” Microbiol. Rev., vol. 60, No. 3, Sep. 1996, pp. 539-574.
[cited by applicant]
Granston et al., “Characterization of a Set of Integration Host Factor Mutants Deficient for DNA Binding,” J. Mol. Biol., vol. 234, Jun. 21, 1993, pp. 45-59.
[cited by applicant]
Greenspan et al., “Defining epitopes: It's not as easy as it seems,” Nature Biotechnology, vol. 17, Oct. 1999, pp. 936-937.
[cited by applicant]
Gustave et al., “Targeting bacterial integration host factor to disrupt biofilms associated with cystic fibrosis”, Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society. 2013; 12(4):384-9.…
[cited by applicant]
Gustave et al., “Targeting bacterial integration host factor to disrupt biofilms associated with cystic fibrosis,” Journal of Cystic Fibrosis, vol. 12, No. 4, Nov. 17, 2012, pp. 384-389.
[cited by applicant]
Gustave et al., Biofilms recovered from the sputum of CF patients contain the bacterial protein integration host factor (IHF), 25th Annual North American Cystic Fibrosis Conference, Anaheim, CA, Nov. 3-5, 2011 (poster),…
[cited by applicant]
Hall-Stoodley et al., “Bacterial Biofilms: From the Natural Environment to Infectious Diseases,” Nature Reviews, Microbiology, vol. 2, Feb. 2004, pp. 95-108.
[cited by applicant]
Hall-Stoodley et al., “Direct Detection of Bacterial Biofilms on the Middle-Ear Mucosa of Children With Chronic Otitis Media,” JAMA, vol. 296, No. 2, Jun. 1, 2007, pp. 202-211.
[cited by applicant]
Hall-Stoodley et al., “Evolving concepts in biofilm infections”, Cellular Microbiology, vol. 11, No. 7, 2009, pp. 1034-1043.
[cited by applicant]
Hall-Stoodley et al., “Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in
[cited by applicant]
Haluzi et al., “Genes Coding for Integration Host Factor Are Conserve in Gram-Negative Bacteria,” Journal of Bacteriology, vol. 173, No. 19, Oct. 1991, pp. 6297-6299.
[cited by applicant]
Harley et al., “The Molecular Action and Regulation of the Testis-Determining Factors, SRY (Sex-Determining Region on the Y Chromosome) and SOX9 [SRY-Related High-Mobility Group (HMG) Box 9],” Endocrine Reviews, vol. 24…
[cited by applicant]
Harriman, et al., “Antibody discovery via multiplexed single cell characterization,” Journal of Immunological Methods (2008) 341:135-145.
[cited by applicant]
Harrison et al., “Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening,” Nature Protocols (2010) 5(7):1236-1254.
[cited by applicant]
Haruta et al., “A possible role of histone-like DNA-binding protein of
[cited by applicant]
Haruta et al., “Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation,” Laboratory Investigation, vol. 90, Apr. 2010, pp. 577-588.
[cited by applicant]
Haurum. “Recombinant polyclonal antibodies: the next generation of antibody therapeutics?” Drug Discovery Today. Jul. 2006; 11(13-14):655-60.
[cited by applicant]
Hoyle et al., “Bacterial Resistance to Antibiotics: The Role of Biofilms,” Prog. Drug Res., vol. 37, 1991, pp. 91-105.
[cited by applicant]
Idicula, et al. “Identification of Biofilms in Post-tympanostomy Tube Otorrhea,” The Laryngoscope (2016) 126(8):1946-1951.
[cited by applicant]
International Search Report and Written Opinion for PCT Patent Application No. PCT/US2014/042201, dated Nov. 28, 2014, 16 pages.
[cited by applicant]
Janeway, “Manipulating the immune response to fight infection,” Immunobiology: The Immune System in Health and Disease, 5th ed.; retrieved online from https://www.ncbi.nlm.nih.gov/books/NBK27131/, 2001, 13 pages.
[cited by applicant]
Jiao et al., “Identification of Biofilm Matrix-Associated Proteins from an Acid Mine Drainage Microbial Community,” Appl & Environ Microbiol., vol. 77, Aug. 2011, pp. 5230-5237.
[cited by applicant]
Jodar et al., “Development of vaccines against meningococcal disease,” Lancet, vol. 359, Apr. 27, 2002, pp. 1499-1508.
[cited by applicant]
John, et al., “Reversible Daptomycin Tolerance of Adherent Staphylococci in an Implant Infection Model,” Antimicrobial Agents and Chemotherapy (2011) 55(7):3510-3516.
[cited by applicant]
Johnson et al., “Chapter 8: Bending and Compaction of DNA by Proteins,” Protein-Nucleic Acid Interactions: Structural Biology, 2008, pp. 176-220.
[cited by applicant]
Joo, et al., “Molecular Basis of In Vivo Formation by Bacterial Pathogens,” Chemistry & Biology (2012) 19:1503-1513.
[cited by applicant]
Jurcisek et al., “Biofilms formed by nontypeable Haemophilus influenzae in vivo contain both double-stranded DNA and type IV pilin protein”, Journal of bacteriology. 2007; 189(10):3868-75. Epub Feb. 27, 2007. doi: 10.11…
[cited by applicant]
Jurcisek et al., “Role of Sialic Acid and Complex Carbohydrate Biosynthesis in Biofilm Formation by Nontypeable Haemophilus influenzae in the Chinchilla Middle Ear,” Infection and Immunity, vol. 73, Jun. 2005, pp. 3210-…
[cited by applicant]
Jurcisek et al., “Biofilms Formed by Nontypeable Haemophilus influenzae In Vivo Contain both Double-Stranded DNA and Type IV Pilin Protein,” Journal of Bacteriology, vol. 189, No. 10, Feb. 15, 2007, pp. 3868-3875.
[cited by applicant]
Justice et al., “Aberrant Community Architecture and Attenuated Persistence of Uropathogenic
[cited by applicant]
Kamashev et al., “The histone-like protein HU binds specifically to DNA recombination and repair intermediates”, The EMBO journal. 2000; 19(23):6527-35.
[cited by applicant]
Kamashev et al., “The histone-like protein HU binds specifically to DNA recombination and repair intermediates,” The EMBO Journal, vol. 19, No. 23, Oct. 13, 2000, pp. 6527-6535.
[cited by applicant]
Kennedy et al., “Passive Transfer of Antiserum Specific for Immunogens Derived from a Nontypeable Haemophilus influenzae Adhesin and Lipoprotein D Prevents Otitis Media after Heterologous Challenge,” Infection and Immun…
[cited by applicant]
Khrapunov, et al., (2006) “Binding then bending: A mechanism for wrapping DNA,” PNAS 103(51):19217-19218.
[cited by applicant]
Kim et al., “Beta-Arm flexibility of HU from
[cited by applicant]
Kim et al., “Proteins Released by Helicobacter pylori In Vitro,” Journal of Bacteriology, vol. 184, No. 22, Nov. 2002, pp. 6155-6162.
[cited by applicant]
Kirketerp-Moller et al., “Distribution, Organization, and Ecology of Bacteria in Chronic Wounds,” Journal of Clinical Microbiology, vol. 46, No. 8, Aug. 2008, pp. 2717-2722.
[cited by applicant]
Kornblit et al., “The genetic variation of the human HMG1 gene,” Tissue Antigens, vol. 70, Apr. 12, 2007, pp. 151-156.
[cited by applicant]
Kristian et al., (2003) “Alanylation of Teichoic Acids Protects
[cited by applicant]
Kyd et al., “Efficacy of the 26-Kilodalton Outer Membrane Protein and Two P5 Fimbrin-Derived Immunogens To Induce Clearance of Nontypeable Haemophilus influenzae from the Rat Middle Ear and Lungs as Well as from the Chi…
[cited by applicant]
Labbé et al., “Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways,” Proc. Natl. Acad. Sci. USA, vol. 9…
[cited by applicant]
Lappann et al., “A dual role of extracellular DNA during biofilm formation of Neisseria meningitidis”, Molecular microbiology. 2010; 75(6):1355-71. doi: 10.1111/j.1365-2958.2010.07054.x.
[cited by applicant]
Lebeaux et al., “From in vitro to in vivo Models of Bacterial Biofilm-Related Infections,” Pathogens, vol. 2, May 13, 2013, pp. 288-356.
[cited by applicant]
Li et al., “Retroviral cDNA Integration: Stimulation by HMG I Family Proteins,” Journal of Virology, vol. 74, No. 23, Dec. 2000, pp. 10965-10974.
[cited by applicant]
Liu et al., “Histone-like DNA binding protein of
[cited by applicant]
Liu et al., “The essentiality and involvement of Streptococcus intermedius histone-like DNA-binding protein in bacterial viability and normal growth,” Molecular Microbiology, vol. 68, No. 5, Apr. 21, 2008, pp. 1268-1282.
[cited by applicant]
Lunsford et al., “DNA-Binding Activities in
[cited by applicant]
Lutz, et al., “Covalent binding of detergent-solubilized membrane glycoproteins to ‘Chemobond’ plates for ELISA,” Journal of Immunological Methods (1990) 129:211-220.
[cited by applicant]
Mahdi et al., “Holliday Junction Resolvases Encoded by Homologous rusA Genes in
[cited by applicant]
Malhotra et al., “Defining the functional epitopes of Integration Host Factor (IHF) to develop a novel biofilm-focused immunotherapeutic against nontypeable Haemophilus influenzae-induced chronic and recurrent otitis me…
[cited by applicant]
Malhotra et al., “Fine mapping the functional epitopes within integration host factor, a novel therapeutic target for nontypeable Haemophilus influenza-induced diseases of the respiratory tract”, Abst. 12th Annual AMA R…
[cited by applicant]
Malhotra et al., Identification of immunoprotective domains within the bacterial DNA-binding protein, integration host factor, 20th Annual Midwest Microbial Pathogenesis Meeting. The Ohio State University, Columbus, OH,…
[cited by applicant]
Malhotra et al., Identification of immunoprotective domains within the bacterial DNA-binding protein, integration host factor, Abst. Seventh Extraordinary International Symposium on Recent Advances in Otitis Media, Stoc…
[cited by applicant]
Malhotra et al., Identification of immunoprotective domains within the bacterial DNA-binding protein, integration host factor, Seventh Extraordinary International Symposium on Recent Advances in Otitis Media, Stockholm,…
[cited by applicant]
Mann, et al., “Modulation of eDNA Release and Degradation Affects
[cited by applicant]
Martinez-Antonio et al. “Functional organization of
[cited by applicant]
Meluleni et al., “Mucoid Pseudomonas aeruginosa Growing in a Biofilm In Vitro Are Killed by Opsonic Antibodies to the Mucoid Exopolysaccharide Capsule but Not by Antibodies Produced During Chronic Lung Infection in Cyst…
[cited by applicant]
Mouw et al., “Shaping the
[cited by applicant]
Mukherjee et al., “Quantitative protein expression and cell surface characteristics of
[cited by applicant]
Murphy et al., “Microbial Interactions in the Respiratory Tract,” The Pediatric Infectious Disease Journal, vol. 28, No. 10, Oct. 2009, pp. S121-S126.
[cited by applicant]
Murphy, et al., “Biofilm formation by nontypeable Haemophilus influenzae: strain variablitiy, outer membrane antigen expression and role of pili,” BMC (2002) Microbiology 2:7, 1-8.
[cited by applicant]
Nakamura et al., “HMG Box A in HMG3 Protein Functions as a Mediator of DNA Structural Alteration Together with Box B,” J. Biochem., vol. 129, No. 4, Feb. 5, 2001, pp. 643-651.
[cited by applicant]
Nash et al., “Overproduction of
[cited by applicant]
NCBI GenBank AAC74782.1 (Jul. 28, 2009).
[cited by applicant]
NCBI Genebank: POA6Y1 (Sep. 13, 2005), 7 pages.
[cited by applicant]
NCBI Sequence NP_415432.1 (Jul. 30, 2009).
[cited by applicant]
Non-Final Office Action in U.S. Appl. No. 15/078,987 dated Jul. 14, 2016, 15 pages.
[cited by applicant]
Non-Final Office Action in U.S. Appl. No. 15/078,987, mailed Mar. 16, 2018, 18 pages.
[cited by applicant]
Non-Final Office Action on U.S. Appl. No. 14/967,228 dated May 19, 2017, 21 pages.
[cited by applicant]
Novotny et al., “Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidates,” Vaccine, vol. 28, No. 1, pp. 2…
[cited by applicant]
Novotny et al., “Monoclonal antibodies against DNA-binding tips of DNABII proteins disrupt biofilms in vitro and induce bacterial clearance in vivo”, EBIOMEDICINE, Aug. 1, 2016, vol. 10, pp. 33-44.
[cited by applicant]
Novotny et al., “Structural stability of Burkholderia cenocepacia biofilms is reliant on eDNA structure and presence of a bacterial nucleic acid binding protein”, PLoS ONE. 2013; 8(6):e67629. Epub Jun. 27, 2013. doi: 10…
[cited by applicant]
Novotny et al., “Structural Stability of Burkholderia cenocepacia Biofilms Is Reliant on eDNA Structure and Presence of a Bacterial Nucleic Acid Binding Protein,” PLoS ONE, vol. 8, No. 6, e67629, Jun. 2013, 15 pages.
[cited by applicant]
Novotny et al., “Detection and characterization of pediatric serum antibody to the OMP P5-homologous adhesin of nontypeable Haemophilus influenzae during acute otitis media,” Vaccine, vol. 20, No. 29-30, Jun. 8, 2002, p…
[cited by applicant]
Novotny et al., “Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidates,” Vaccine, vol. 28, No. 1, Aug. …
[cited by applicant]
Novotny et al., “Epitope mapping of the Outer Membrane Protein P5-Homologous Fimbrin Adhesin of Nontypeable Haemophilus influenzae,” Infection and Immunity, vol. 68, No. 4, Apr. 2000, pp. 2119-2128.
[cited by applicant]
Novotny et al., “Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae,…
[cited by applicant]
Novotny et al., “The Fourth Surface-Exposed Region of the Outer Membrane Protein P5-Homologous Adhesin of the Nontypable Haemophilus influenzae Is an Immunodominant But Nonprotective Decoying Epitope,” The Journal of Im…
[cited by applicant]
Novotny, “Development of a novel biofilm-focused immunotherapeutic against NTHI-induced otitis media”, 18th International Symposium on Recent Advances in Otitis Media, National Harbor, MD, Jun. 7-11, 2015 (presentation)…
[cited by applicant]
Novotny, et al., “Monoclonal antibodies against DNA-binding tips of DNABII proteins disrupt biofilms in vitro and induce bacterial clearance in vivo,” 2016, EBioMedicine 10:33-44.
[cited by applicant]
Nowakowska, J. et al. (2014) “Foreign Body Infection Models to Study Host-Pathogen Response and Antimicrobial Tolerance of Bacterial Biofilm,” Antibiotics 3:378-397, Aug. 2014.
[cited by applicant]
Oberto et al., “Histones, HMG, HU, IHF: Même combat,” Biochimie, vol. 76, 1994, pp. 901-908.
[cited by applicant]
Ordway et al., “Evaluation of Standard Chemotherapy in the Guinea Pig Model of Tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 54, May 2010, pp. 1820-1833.
[cited by applicant]
Otto, “
[cited by applicant]
Pedulla et al., “A novel host factor for integration of mycobacteriophage L5,” Proc. Natl. Acad. Sci. USA, vol. 93, Dec. 1996, pp. 15411-15416.
[cited by applicant]
Percival, S.L. et al. (2015) “Biofilms and Wounds: An Overview of the Evidence,” Advances in Wound Care 4(7):373-381.
[cited by applicant]
Petersen et al., “Biofilm Mode of Growth of
[cited by applicant]
Pethe et al., “Mycobacterium smegmatis laminin-binding glycoprotein shares epitopes with
[cited by applicant]
Priyadarshini et al., “The nucleoid-associated protein HUß affects global gene expression in Porphyromonas gingivalis”, Microbiology. 2013; 159(Pt 2):219-29. First Published: Feb. 1, 2013.
[cited by applicant]
Prymula et al., “Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomized double-bli…
[cited by applicant]
Reffuveille et al., “A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms”, Antimicrobial Agents and Chemotherapy, vol. 58, No. 9, Sep. 2014, pp. 5363-5371.
[cited by applicant]
Restriction Requirement on U.S. Appl. No. 14/967,228 dated Dec. 23, 2016, 7 pages.
[cited by applicant]
Rice et al., “1IHF Integration Host Factor/DNA Complex,” PDB ID: 1IHF: Rice, P.A. et al. (1996), 1 page; retrieved online from http://www.rcsb.org/pdb/explore.do?structureId=IHF, 2 pages.
[cited by applicant]
Rice et al., “Crystal Structure of an IHF-DNA Complex: A Protein-Induced DNA U-Turn,” CELL, vol. 87, No. 7, pp. 1295-1306 (Dec. 27, 1996).
[cited by applicant]
Rice et al., “Crystal Structure of an IHF-DNA Complex: A Protein-Induced DNA U-Turn,” Cell, vol. 87, No. 7, Dec. 27, 1996, pp. 1295-1306.
[cited by applicant]
Rouviere-Yaniv et al., “Characterization of a novel, low-molecular-weight DNA-binding protein from
[cited by applicant]
Rudikoff et al., “Single amino acid substitution altering antigen-binding specificity,” Proc. Natl. Acad. Sci. USA, vol. 79, No. 6, Mar. 1982, pp. 1979-1983.
[cited by applicant]
Sapi et al., “Characterization of Biofilm Formation by Borrelia burgdorferi In Vitro,” PLOS One, vol. 7, No. 10, Oct. 2012, pp. 1-11.
[cited by applicant]
Schwartz et al., (2012) “Functional Amyloids Composed of Phenol Soluble Modulins Stabilize
[cited by applicant]
Segall et al., “Architectural elements in nucleoprotein complexes: interchangeability of specific and non-specific DNA binding proteins,” The EMBO Journal, vol. 13, No. 19, 1994, pp. 4536-4548.
[cited by applicant]
Shahrooei et al., “Inhibition of
[cited by applicant]
Shields, R.C. et al. (2013) “Efficacy of a Marine Bacterial Nuclease against Biofilm Forming Microorganisms Isolated from Chronic Rhinosinusitis,” PLoS ONE 8(2):e55339, 1-13.
[cited by applicant]
Singh et al., “Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms,” Nature, vol. 407, No. 12, Oct. 12, 2000, pp. 762-764.
[cited by applicant]
Skolnick, J. et al. (2000) “From genes to protein structure and function: novel applications of computational approaches in the genomic era,” Trends in Biotechnology 18:34-39.
[cited by applicant]
Smith et al., “Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid,” Cell, vol. 85, Apr. 19, 1996, pp. 229-236.
[cited by applicant]
Stinson, et al. “Streptococcal Histone-Like Protein: Primary Structure of hlpA and Protein Binding to Lipoteichoic Acid and Epithelial Cells,” Infection and Immunity, 1998, 66(1):259-265.
[cited by applicant]
Stoltz et al., “Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth,” www.ScienceTranslationMedicine.org, vol. 2, No. 29, Apr. 28, 2010, pp. 1-8.
[cited by applicant]
Stros et al., “The HMG-box: a versatile protein domain occurring in a wide variety of DNA-binding proteins,” Cell. Mol. Life Sci., vol. 64, No. 19-20, Jun. 29, 2007, pp. 2590-2606.
[cited by applicant]
Sun et al., “Inhibition of Biofilm Formation by Monoclonal Antibodies against
[cited by applicant]
Swinger et al., “IHF and HU: flexible architects of bent DNA,” Current Opinion in Structural Biology, vol. 14, No. 1, 2004, pp. 28-35.
[cited by applicant]
Takeda, “Polyhistidine Affinity Chromatography for Purification and Biochemical Analysis of Fungal Cell Wall-Degrading Enzymes,” Affinity Chromatography, Dr. Sameh Magdeldin (Ed.), ISBN: 978-953-51-0325-7, In Tech, 2012…
[cited by applicant]
Taudte et al., “Alanine mutagenesis of high-mobility-group-protein-1 box B (HMG1-B),” Biochem. J., vol. 347, Feb. 25, 2000, pp. 807-814.
[cited by applicant]
Teter et al., “DNA Bending and Twisting Properties of Integration Host Factor Determined by DNA Cyclization,” Plasmid, vol. 43, 2000, pp. 73-84.
[cited by applicant]
Tetz et al., “Effect of DNase and Antibiotics on Biofilm Characteristics,” Antimicrobial Agents and Chemotherapy, vol. 53, No. 3, Mar. 2009, pp. 1204-1209.
[cited by applicant]
Thomas, “HMG1 and 2: architectural DNA-binding proteins,” Biochemical Society Transactions, vol. 29, Pt. 4, Apr. 12, 2001, pp. 395-401.
[cited by applicant]
Thurnheer et al., “Colonisation of gingival epithelia by subgingival biofilms in vitro: role of ‘red complex’ bacteria”, Arch Oral Biol., vol. 59, No. 9, Sep. 2014, pp. 1-24.
[cited by applicant]
Tsaras et al., “Incidence, Secular Trends, and Outcomes of Prosthetic Joint Infection: A Population-Based Study, Olmsted County, Minnesota, 1969-2007,” Infect Control Hosp Epidemiol., vol. 33, No. 12, Dec. 2012, pp. 120…
[cited by applicant]
Van Schaik et al., “DNA Binding: a Novel Function of Pseudomonas aeruginosa Type IV Pili,” Journal of Bacteriology, vol. 187, No. 4, Feb. 2005, pp. 1455-1464.
[cited by applicant]
Whitchurch et al., “Extracellular DNA Required for Bacterial Biofilm Formation,” Science, vol. 295, No. 5559, Feb. 22, 2002, p. 1487, 1 page.
[cited by applicant]
Whitchurch et al., “Extracellular DNA Required for Bacterial Biofilm Formation,” Science, vol. 295, No. 5559, Feb. 22, 2002, Supplementary Material, 2 pages.
[cited by applicant]
Winters et al., “Isolation and Characterization of a
[cited by applicant]
Winther et al., “Location of Bacterial Biofilm in the Mucus Overlying the Adenoid by Light Microscopy,” Head & Neck Surgery, vol. 135, No. 12, Dec. 2009, pp. 1239-1245.
[cited by applicant]
Woischnig et al., “High Affinity Native Human Monoclonal Antibody with Broad Cross-Species Biofilm Disrupting Activity” poster presented at ICAAC Meeting on Sep. 20, 2015, available at www.trellisbio.com/assets/docs/ICA…
[cited by applicant]
Yoshida, “HMG box proteins: general architectural elements in the assembly of active transcription complex,” SEIKAGAKU Biochemistry (1996) 68(12):1829-1834.
[cited by applicant]
Zimmerli et al., “Pathogenesis of Foreign Body Infection,” J. Clin. Invest (1984) 73(4):1191-1200.
[cited by applicant]
Zimmerli et al., “Pathogenesis of Foreign Body Infection: Description and Characteristics of an Animal Model,” The Journal of Infectious Diseases, vol. 146, No. 4, Oct. 1982, pp. 487-497.
[cited by applicant]
Zulianello et al., “The HimA and HimD subunits of integration host factor can specifically bind to DNA as homodimers,” The EMBO Journal, vol. 13, No. 4, Apr. 1, 1994, pp. 1534-1540.
[cited by applicant]
Devaraj et al., “The DNABII family of proteins is comprised of the only nucleoid associated proteins required for nontypeable Haemophilus influenzae biofilm structure”, MicrobiologyOpen, 2018, 13 pages.
[cited by applicant]
Trifiro et al., “Ghost Mycobacteria on Gram Stain,” Journal of Clinical Microbiology, Jan. 1990, vol. 28, No. 1, pp. 146-147.
[cited by applicant]
U.S. Notice of Allowance dated Jun. 24, 2024, for U.S. Appl. No. 16/475,654.
[cited by applicant]